# Hyperglycemia and glycemic control in critically ill and hospitalized patients

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/hyperglycemia-and-glycemic-control-in-critically-ill-and-hospitalized-patients/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers explores the impact of hyperglycemia, the use of intensive insulin therapy, and glycemic control on health outcomes in critically ill and surgical patients, with a focus on infection risk, mortality, and the inflammatory response. It also investigates the association between hyperglycemia and various medical conditions such as myocardial infarction, stroke, and traumatic brain injury. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t11623 |
| Works | 350 |

## Topic papers all

Showing 15 of 350.

- [Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes](https://scholariq.org/papers/empagliflozin-cardiovascular-outcomes-and-mortality-in-type-2-diabetes/)
- [Effects of Intensive Glucose Lowering in Type 2 Diabetes](https://scholariq.org/papers/effects-of-intensive-glucose-lowering-in-type-2-diabetes/)
- [Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes](https://scholariq.org/papers/intensive-blood-glucose-control-and-vascular-outcomes-in-patients-with-type-2/)
- [Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction](https://scholariq.org/papers/dapagliflozin-in-patients-with-heart-failure-and-reduced-ejection-fraction/)
- [Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes](https://scholariq.org/papers/semaglutide-and-cardiovascular-outcomes-in-patients-with-type-2-diabetes/)
- [Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes](https://scholariq.org/papers/dapagliflozin-and-cardiovascular-outcomes-in-type-2-diabetes/)
- [Dapagliflozin in Patients with Chronic Kidney Disease](https://scholariq.org/papers/dapagliflozin-in-patients-with-chronic-kidney-disease/)
- [Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure](https://scholariq.org/papers/cardiovascular-and-renal-outcomes-with-empagliflozin-in-heart-failure/)
- [Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes](https://scholariq.org/papers/glucose-control-and-vascular-complications-in-veterans-with-type-2-diabetes/)
- [Empagliflozin in Heart Failure with a Preserved Ejection Fraction](https://scholariq.org/papers/empagliflozin-in-heart-failure-with-a-preserved-ejection-fraction/)
- [Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range](https://scholariq.org/papers/clinical-targets-for-continuous-glucose-monitoring-data-interpretation/)
- [Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus](https://scholariq.org/papers/saxagliptin-and-cardiovascular-outcomes-in-patients-with-type-2-diabetes/)
- [Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis](https://scholariq.org/papers/intensive-insulin-therapy-and-pentastarch-resuscitation-in-severe-sepsis/)
- [Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes](https://scholariq.org/papers/bariatric-surgery-versus-intensive-medical-therapy-for-diabetes-5-year-outcomes/)
- [Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction](https://scholariq.org/papers/dapagliflozin-in-heart-failure-with-mildly-reduced-or-preserved-ejection/)

## Topic primary papers

Showing 15 of 80.

- [Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes](https://scholariq.org/papers/glucose-control-and-vascular-complications-in-veterans-with-type-2-diabetes/)
- [Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis](https://scholariq.org/papers/intensive-insulin-therapy-and-pentastarch-resuscitation-in-severe-sepsis/)
- [Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): Effects on mortality at 1 year](https://scholariq.org/papers/randomized-trial-of-insulin-glucose-infusion-followed-by-subcutaneous-insulin/)
- [American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control](https://scholariq.org/papers/american-association-of-clinical-endocrinologists-and-american-diabetes/)
- [Management of Hyperglycemia in Hospitalized Patients in Non-Critical Care Setting: An Endocrine Society Clinical Practice Guideline](https://scholariq.org/papers/management-of-hyperglycemia-in-hospitalized-patients-in-non-critical-care/)
- [Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data](https://scholariq.org/papers/intensive-insulin-therapy-and-mortality-among-critically-ill-patients-a-meta/)
- [Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity](https://scholariq.org/papers/intense-metabolic-control-by-means-of-insulin-in-patients-with-diabetes-mellitus/)
- [Admission Glucose and Mortality in Elderly Patients Hospitalized With Acute Myocardial Infarction](https://scholariq.org/papers/admission-glucose-and-mortality-in-elderly-patients-hospitalized-with-acute/)
- [Follow-up of Glycemic Control and Cardiovascular Outcomes in Type 2 Diabetes](https://scholariq.org/papers/follow-up-of-glycemic-control-and-cardiovascular-outcomes-in-type-2-diabetes/)
- [Intensive Intraoperative Insulin Therapy versus Conventional Glucose Management during Cardiac Surgery](https://scholariq.org/papers/intensive-intraoperative-insulin-therapy-versus-conventional-glucose-management/)
- [Intraoperative Hyperglycemia and Perioperative Outcomes in Cardiac Surgery Patients](https://scholariq.org/papers/intraoperative-hyperglycemia-and-perioperative-outcomes-in-cardiac-surgery/)
- [Hyperglycemia and Acute Coronary Syndrome](https://scholariq.org/papers/hyperglycemia-and-acute-coronary-syndrome/)
- [Implementation of a Safe and Effective Insulin Infusion Protocol in a Medical Intensive Care Unit](https://scholariq.org/papers/implementation-of-a-safe-and-effective-insulin-infusion-protocol-in-a-medical/)
- [Frequency, Risk Factors, and Outcome of Hyperlactatemia After Cardiac Surgery](https://scholariq.org/papers/frequency-risk-factors-and-outcome-of-hyperlactatemia-after-cardiac-surgery/)
- [Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery](https://scholariq.org/papers/hyperglycemia-during-cardiopulmonary-bypass-is-an-independent-risk-factor-for/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.